On May 9, 2024, Invivyd, Inc., a biotechnology company based in Waltham, Massachusetts, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC). The filing is intended to register an additional 3,304,820 shares of common stock under the company's 2021 Equity Incentive Plan. This move follows the provisions of the 2021 Plan, which allows for an automatic increase in the number of shares reserved for issuance each year. The newly registered shares are set to support the company's equity incentive efforts, aimed at attracting and retaining talent. Invivyd, Inc. has incorporated by reference its previous filings, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and other relevant documents. The company, identified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, has also included various exhibits and legal opinions in the registration statement.

On May 9, 2024, Invivyd, Inc., a biotechnology company based in Waltham, Massachusetts, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC). The filing is intended to register an additional 3,304,820 shares of common stock under the company's 2021 Equity Incentive Plan. This move follows the provisions of the 2021 Plan, which allows for an automatic increase in the number of shares reserved for issuance each year. The newly registered shares are set to support the company's equity incentive efforts, aimed at attracting and retaining talent. Invivyd, Inc. has incorporated by reference its previous filings, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and other relevant documents. The company, identified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, has also included various exhibits and legal opinions in the registration statement.